CXCR4 and marginal zone lymphoma: This, together with the provided benefit of CXCR4-targeted PET/CT as summarized above, led the experts to suggest that [68Ga]PentixaFor PET might serve as a valuable diagnostic tool for MZL including MALT lymphoma, and should be further developed in prospective clinical trials.